A range of Streptococcus bacteria are able to interact with blood platelets to form a thrombus (clot). Streptococcus gordonii is ubiquitous within the human oral cavity and amongst the common pathogens isolated from subjects with infective endocarditis. Two cell surface proteins, Hsa and Platelet adherence protein A (PadA), in S. gordonii mediate adherence and activation of platelets.
| INTRODUCTION
Streptococcus, Staphylococcus, and Enterococcus bacteria account for >80% cases of infective endocarditis (Muñoz et al., 2015; Slipczuk et al., 2013) and are able to trigger activation or aggregation of blood platelets into a clot or thrombus (Fitzgerald, Foster, & Cox, 2006; Kerrigan, 2015) . Viridans-group streptococci that enter the bloodstream in otherwise healthy subjects almost always originate from the complex microbial communities present within the human oral cavity (Cahill & Prendergast, 2015; McNicol & Israels, 2010; Nilson, Olaison, & Rasmussen, 2015) . Accordingly, there is a predictive link between levels of oral hygiene and the risk of cardiovascular disease (Lockhart et al., 2009) . Platelet adhesion and activation by oral streptococci occurs by several different mechanisms (Cognasse et al., 2015; McNicol, 2015) . For Streptococcus gordonii, S. oralis and S. sanguinis, a common primary interaction occurs with platelet integrin receptor GPIb mediated by a bacterial surface serine-rich repeat protein (Deng et al., 2014) . In S. sanguinis, a direct interaction between serine-rich repeat protein SrpA and GPIbα leads to platelet rolling over immobilized bacteria and adhesion at low shear (Kerrigan et al., 2002; Plummer et al., 2005) .
S. gordonii serine-rich repeat glycoprotein designated Hsa (Takahashi, Konishi, Cisar, & Yoshikawa, 2002) , or GspB (Bensing & Sullam, 2002) , seems to act in a similar manner (Bensing, López, & Sullam, 2004; Kerrigan et al., 2007) . Hsa and GspB recognize structurally-distinct sialic acid-oligosaccharides on GPIb (Takamatsu et al., 2005) . Once engaged with the streptococci the platelets become activated, spread, aggregate, and initiate thrombus formation, under which conditions, the bacteria are well protected from host immune defences and antibiotics (Jenne & Kubes, 2015; Jung et al., 2015) .
The mechanisms by which platelets are activated by streptococci following adhesion are poorly understood. Recent work has identified the importance of specific antibodies in bacterial activation of platelets through receptor FcγRIIa (Arman et al., 2014; Pampolina & McNicol, 2005; Tilley et al., 2013) . In S. gordonii, a ubiquitous human oral bacterium, there is direct activation of FcγRIIa integrin (non-antibody mediated), and then inside-out activation of the most highly-expressed platelet receptor GPIIbIIIa (α IIb β 3 ) . Further activation is associated with secretion of granules and secondary mediators,
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. filopodia formation (spreading), generation of ADP and thromboxane A2 (TxA2) to reinforce α IIb β 3 activation (Cox, Kerrigan, & Watson, 2011) , and then aggregation with nearby-activated platelets via fibrinogen (Moriarty et al., 2015) .
We have identified a protein designated Platelet adherence protein A (PadA), that is expressed on the surface of S. gordonii, and which interacts directly with platelets . PadA precursor (3,646 amino acid [aa] residues) comprises a N-terminal region of 1,328 aa residues containing a von Willebrand Factor (vWF)-like domain (aa residues 72-229), and a C-terminal region comprising 14 blocks of aa residue repeats ) with a bacterial cell wall anchor region and sortase (LPxTG) motif (Mazmanian, Ton-That, & Schneewind, 2001 ) (see Figure 1) . PadA, unlike Hsa, does not interact with sialylated GPIb , but was shown to bind directly to the platelet receptor α IIb β 3 over-expressed on the surface of Chinese hamster ovary cells . Binding of PadA to α IIb β 3 on platelets results in platelet activation; however, it is not known if PadA is able to activate platelets on its own, or if it requires a coactivator. Previous results suggest that α IIb β 3 may bind to S. gordonii via common integrin-recognition motifs (RGT and AGD) present within the N-terminal region of PadA (Keane et al., 2013) .
Recently, it has emerged that another motif, NGR (Asn-Gly-Arg), found in the D domain of fibrinogen on each of the β and γ chains, plays an important role in the interaction of α IIb β 3 with fibrinogen (Moriarty et al., 2015) . A similar motif is found within the N-terminal region of PadA, raising the possibility that this might be a key factor in recognition of α IIb β 3 by PadA.
In this article, we have investigated the relative functions of Hsa and PadA in S. gordonii platelet interactions, and in bacterial cell binding to various extracellular matrix components that may be exposed at sites of endothelial damage, for example, fibronectin or vitronectin. We have also studied in more detail the interactions of the mature N-terminal F2 region (657 aa residues) of PadA with platelets and matrix components, and more specifically the relative roles of the integrin-recognition motifs and NGR in S. gordonii host interactions.
2 | RESULTS 2.1 | Expression of padA and hsa in deletion mutants and complemented strains A diagrammatic representation of PadA protein is presented in Figure 1 together with a visual expansion of the 690 aa-residue precursor N-terminal domain (F2) of main focus in this paper, and the corresponding aa sequence. Three integrin-like recognition motifs within the F2 domain are highlighted. To investigate further the functional properties of the PadA protein, the entire coding region was cloned into replicative plasmid vector pMSP downstream of a nisin-inducible promoter (see 4). The hsa gene was cloned in the same way as previously described (Jakubovics, Brittan, Dutton, & Jenkinson, 2009 ). Because Hsa is glycosylated by various products encoded by genes within the hsa-accessory secretion system locus (Zhou & Wu, 2009) Hsa production was detected with succinylated-wheat germ agglutinin (sWGA), which recognizes the glycosylated protein (Takahashi, Yajima, Cisar, & Konishi, 2004) . Hsa was well-expressed ectopically in the complemented Δhsa and ΔpadA Δhsa mutants when induced with 50 ng nisin ml -1 (Figure 2b ,c). Higher nisin concentrations were growth-inhibitory. Production of Hsa from the chromosomal locus in the ΔpadA mutant was unaffected and was similar to wild type strain DL1 expression levels ( Figure 2c ; Petersen et al., 2010) . ously shown that PadA also is involved in S. gordonii binding platelets . This is confirmed (Figure 3 ) with the ΔpadA mutant being approximately 30% reduced in levels of platelet adherence, and the ΔpadA Δhsa mutant >80% reduced in binding platelets.
Expression of padA in the ΔpadA Δhsa mutant does not restore any level of platelet adhesion, but expression of hsa restored platelet binding levels to~70% of wild type ( Figure 3 ). These results show that interaction of PadA with resting platelets requires the presence of Hsa.
2.3 | PadA integrin-recognition motifs are essential for binding platelets
The above results suggest that Hsa and PadA might participate in a two-step reaction with platelets. We envisage that Hsa interacts with GPIb (Bensing et al., 2004) resulting in inside-out signalling, activation of α IIb β 3 , and PadA interacting with activated α IIb β 3 (Keane et al., 2013) . In support of this hypothesis, a padA mutant was unaffected in binding purified α IIb β 3 but was abrogated in binding α IIb β 3 on the surface of Chinese hamster ovary cells . The purified PadA-F2 fragment (Figure 1 ) binds weakly to non-activated platelets ( Figure 4a ) but at high levels to TRAP-activated platelets ( Figure 4b ). We were interested in determining the role of the NGR motif within PadA-F2 region because this same motif is present in fibrinogen and has been shown to interact with α IIb β 3 and activate platelets (Moriarty et al., 2015) . Alanine substitutions of integrin-like recognition motifs NGR, RGT, or AGD, to AAA in each case, individually had no significant effects on binding of F2 fragment to activated platelets ( Figure 4b) . However, when all three motifs were substituted, FIGURE 2 Expression of PadA and Hsa proteins by S. gordonii DL1 wild type, mutants and complemented mutants. (a) (composite), SDS-PAGE gel, and corresponding Western immunoblot of PadA (~350 kDa) in cell wall proteins extracted from: (1) DL1; (2) UB2723 ΔpadA; (3) UB2724 ΔpadA/pMSP-padA; (4) UB2773 ΔpadA Δhsa; and (5) UB2775 ΔpadA Δhsa/pMSP-padA. In lanes 3 and 5, protein expression was induced with 10 ng nisin ml
. (b) (composite), whole cell dot blots reacted with sWGA of: (1) DL1; (2) UB2029 Δhsa; (3) UB2773 ΔpadA Δhsa; (4) UB2777 ΔpadA Δhsa/pMSP-hsa; (5) UB2777 + 10 ng nisin ml ; and (6) UB2777 + 50 ng nisin ml −1 .
(c) Biotinylated sWGA binding to immobilized bacterial cells (2 × 10 7 per well) followed by HRP-streptavidin to detect Hsa as described in 4.
Figures in parentheses indicate ng ml −1 nisin added to cultures to induce expression of Hsa in the complemented strain UB2777 ΔpadA Δhsa/pMSP-hsa. Error bars represent ±SEM from two independent experiments (n = 2). * P < 0.05 Previously, we have suggested that the RGT and AGD motifs have little or no role in supporting platelet adhesion, but are involved in the transformation of the platelet biconcave disc through formation of filopodia and lamellipodia to a fully spread cell (Keane et al., 2013 ). Accordingly, we tested the effect of NGR AAA mutation on platelet spreading and found that for those platelets that adhered, spreading was unaffected ( Figure 5 ). Taken collectively, these results suggest that NGR plays a major role in directing adhesion of platelets, while AGD and RGT promote spreading.
FIGURE 4 Adhesion of non-activated or TRAP-activated platelets to immobilized recombinant PadA-F2 region fragments under static conditions. Recombinant PadA protein fragments were immobilized onto microtitre plate wells (10 μg per well), and non-specific binding sites were blocked with BSA. Gel-filtered platelets were either non-activated (a) or activated by addition of TRAP (Thrombin Receptor Activating Peptide; b) and were incubated with the immobilized proteins at 37°C for 45 min (2 × 10 7 platelets per well). Platelet adherence was determined by phosphatase assay. RGT AAA , AGD AAA , NGR AAA , and so forth indicate the motifs within the various F2 fragments that were alanine-substituted to AAA. Error bars represent ±SEM from three independent experiments (n = 3). (To & Midwood, 2011) . It is known that Hsa is involved in S. gordonii binding to pFn by recognition of sialylated regions on the molecule (Jakubovics et al., 2009 ). Accordingly, we tested the ΔpadA or Δhsa mutants and complemented strains in adherence to pFn and to cFn. Levels of binding were slightly higher to cFn, but the overall adherence patterns of the strains were identical; therefore, we only present the data for binding to cFn. The ΔpadA mutant was approximately 25% reduced in binding cFn, while the complemented strain was above wild type levels of binding ( Figure 6 ). These adherence events were reduced by 50-60% when the cFn was desialylated 
| Functions of PadA and Hsa in binding vitronectin
Vitronectin ( . Error bars represent ±SEM from three independent experiments (n = 3). * P < 0.05 for comparisons indicated; § P < 0.05 for neuraminidase-treated cFn versus untreated
In subsequent biofilm formation, the ΔpadA mutant was 50% decreased in biomass compared to wild type, and complementation with padA restored biomass to slightly above wild type levels , respectively. Error bars represent ±SEM from three independent experiments (n = 3). * P < 0.05 for comparisons indicated; § P < 0.05 for neuraminidase-treated Vn versus untreated FIGURE 8 S. gordonii strains adherence to salivary pellicle and biofilm formation. Cover slips were coated with salivary pellicle and incubated with streptococcal cells (5 × 10 7 per well) for 2 hr at 37°C for adherence (grey columns) or in YPT-Glc medium for 16 hr at 37°C for biofilm formation (black columns). Bacterial cells adhered, and biofilm biomass values were quantified by staining with crystal violet as described in 4. Expression of PadA or Hsa proteins by complemented strains was induced with 10 ng or 50 ng nisin ml
, respectively. Error bars represent ±SEM from three independent experiments (n = 3). * P < 0.05 for biofilm comparisons indicated; § P < 0.05 for significantly different adherence versus DL1 FIGURE 9 Adhesion of PadA-F2 region fragments to cellular fibronectin (cFn), vitronectin (Vn), or salivary pellicle (SP). cFn, Vn, or saliva were immobilized onto microtitre plate wells and non-specific binding sites were blocked with BSA (black columns). Wells coated with cFn, Vn, or salivary glycoproteins were also incubated with 0.001 U neuraminidase (sialidase) for 2 hr at 37°C, washed, and blocked with BSA (grey columns). Recombinant proteins (100 μg ml −1 ) were incubated with substrata for 2 hr at 37°C and amounts bound measured with anti-tetra-His mouse antibodies and HRP-conjugated anti-mouse IgG antibodies as described in 4. F2, unmodified fragment; F2*, fragment containing NGR, RGT, and AGD motifs all alanine-substituted to AAA. Error bars represent ±SEM from three independent experiments (n = 3). * P < 0.05 compared with corresponding F2 values
gordonii is a component of the normal microbiota of the human oral cavity and plays a pivotal role in the development of microbial communities on the tooth surfaces and gingival crevices (Jenkinson, 2011; Wright et al., 2013) . These communities provide a reservoir for bacteria to enter the circulation where they may interact with blood platelets and cause unwanted thrombus generation. This can lead to infective endocarditis, which is characterized by the formation of vegetations on the heart valves (Moreillon & Que, 2004 ). Significant advances in our understanding of how S. gordonii, and other mitisgroup oral bacteria, interact with platelets have been made in recent years.
In addition to the knowledge about S. gordonii Hsa and GspB proteins (Takahashi et al., 2002; Xiong, Bensing, Bayer, Chambers, & Sullam, 2008) , and how they are able to interact with platelet integrin GPIb (Takamatsu et al., 2005) , we have demonstrated that PadA surface protein can bind to platelets in a α IIb β 3 -dependent manner causing dense granule secretion and full platelet spreading . The N-terminal region of 1328 aa residues interacts with platelets (Keane et al., 2013; Petersen et al., 2010) , surface proteins, such as CshA and Hsa, are reported to provide extended conformations (McNab et al., 1999; Takahashi et al., 2002) that may assist in capture of their ligands even under conditions of shear or flow (Kerrigan et al., 2007) .
In the first part of the present study, we focused on the roles of three integrin-like recognition motifs within the N-terminal PadA-F2 fragment (657 aa residues) in the interactions of PadA with platelets.
We showed previously that neither RGT (416) (417) (418) nor AGD (485) (486) (487) were necessary for supporting static or shear-induced platelet adhesion, but both motifs contributed to platelet spreading (Keane et al., 2013) . This is in keeping with the data suggesting that Hsa is essential for platelet capture under shear and thus responsible for platelet rolling (Bensing et al., 2004; Kerrigan et al., 2007) . Firm adhesion is then complete when platelet integrin α IIb β 3 interacts with PadA . Recent evidence indicates that another motif, NGR, within fibrinogen is responsible for interaction with α IIb β 3 and triggering platelet activation (Moriarty et al., 2015) . In light of this discovery, we investigated the role of an identical motif NGR (214) (215) (216) within the N-terminal region of PadA to direct interactions with platelets. In our experiments with platelets that were specifically in resting state, we found that the PadA-F2 fragment bound these only weakly ( Figure 4a ). However, the immobilized PadA-F2 region bound TRAP-activated platelets, so this would be in keeping with the notion that PadA preferentially interacts with α IIb β 3 that is in an activated complex with GPIb following Hsa-binding. Confirming our previous studies, we showed that RGT and AGD were not essential for PadA-F2 binding to TRAP-activated platelets. However, binding of the PadA-F2 fragment to activated platelets required the combined activities of NGR, RGT, and AGD, because alanine-substitutions of all of these motifs ablated adhesion (Figure 4b ). Moreover, we could not demonstrate that the NGR motif alone was necessary for full platelet spreading, while RGT and AGD motifs clearly contribute to the full spreading process (Keane et al., 2013) . In summary, we are nearing the situation in which we could potentially target these three motifs within PadA as a means to controlling unwanted platelet activation by circulating S. gordonii, and by other oral streptococci that express
PadA-like proteins.
In this study, we have also utilized gene knockouts and respective remains platelet bound (Parker, Stone, White, & Seinshaw, 1989) . Vn forms complexes with plasminogen activator inhibitor-1 (PAI-1) and thus behaves as a physiological inhibitor of active thrombin. Conversely, Vn also appears to stabilize the thrombus and, so, plays a dual role in mediating platelet adhesion (Thiagarajan & Kelly, 1988) and aggregation (Reheman et al., 2005) . Vn carries binding sites for heparin, PAI-1, integrins, collagen and plasminogen (Ekmekçi & Ekmekçi, 2006) and also binds α IIb β 3 . Thus, S. gordonii might be able to interact with platelets via Vn, which may be bound to β 3 integrins or to surfaceassociated collagen. Furthermore, bacteria coated with Vn are able to evade the membrane attack complex (MAC) by blocking complement components (C5b-7 complex and C9) and conferring serum resistance (Singh et al., 2010) . This of course would be a crucially important prop- Bacto-tryptone, 4 g l −1 yeast extract, 4 g l −1 K 2 HPO 4 , adjusted to pH 7.5 with HCl) containing 0.5% glucose (TY-Glc) was employed for protein purification from S. gordonii UB2870 ΔpadA/pMSP-padA 6His .
Protein expression from pMSP was under control of a nisin-inducible (10-50 ng ml −1 ) promoter (Bryan, Bae, Kleerebezem, & Dunny, 2000; Hirt, Erlandsen, & Dunny, 2000) . Escherichia coli strains DH5α, JM109, XL1-Blue, Stellar® and BL21 for plasmid preparation and protein expression were grown on LB agar or in LB broth at 37°C. Antibiotics were incorporated where necessary for streptococci [5 μg erythromycin (Em) ml
; 100 μg spectinomycin (Sp) ml −1 ; 250 μg kanamycin (Kn) ml
] or E. coli [100 μg ampicillin (Ap) ml −1 ; 250 μg Em ml
].
| Generation of S. gordonii gene knockout strains
Plasmids or PCR amplimers were purified using QIAquick Spin
Miniprep or PCR Purification kits respectively (Qiagen, Manchester, UK). Oligonucleotides (Table 1) were synthesised by MWG Eurofins (Wolverhampton, UK). Chromosomal DNA was extracted from mutanolysin-treated S. gordonii DL1 cells, as described previously (Jenkinson, 1987) . DNA restriction and modification enzymes were used under the conditions specified by the manufacturer (New England Biolabs, Hitchin, Herts, UK).
The padA gene of S. gordonii DL1 was deleted by allelic exchange with the Sp resistance determinant aad9. PCR amplification using Expand Long PCR System (Roche, Burgess Hill, West Sussex, UK) with primers padA.F1/padA.R1 and padA.F2/padA.R2 and S. gordonii DL1 chromosomal DNA template generated two fragments comprising the flanking sequences of the padA gene (676 BP, 518 BP) with a unique NarI site at their 3′ and 5′ ends, respectively. These were stitched together in a second round of PCR using primers padA.F1/padA.R2 generating a 1155-bp amplimer with an internal unique NarI site. The fragment was subsequently cloned into pGEM-T Easy to generate construct pGEM-padAflank and transformed into chemically-induced competent cells (Hanahan, 1983) of Escherichia coli XL1-Blue. The aad9 gene was PCR amplified from plasmid pFW5 (Podbielski, Spellerberg, Woischnik, Pohl, & Lútticken, 1996) using primers aad9F.
NarI/aad9R.NarI and then sub-cloned into the NarI site of pGEMpadAflank to generate construct pGEM-padAflank::aad9. PCR amplification from pGEM-padAflank::aad9 with primers padA.F1/padA.R2 generated amplimer padAflank::aad9, which was transformed into S. gordonii DL1 as described by Haisman and Jenkinson (1991) of the padA gene with aad9. Primers padA.F1/padA.R2 were utilized to amplify with PrimeSTAR Max polymerase (Takara Biotechnology, Shiga, Japan) a 2-kb fragment from UB2723 chromosomal DNA. The amplimer was purified and transformed into S. gordonii UB2029 with selection for Kn R and Sp R , and colonies were screened by PCR using primers aad9.seqF/padA.R2 to detect the aad9 cassette. Several transformants were checked by sequencing PCR products generated from across the loci and a representative transformant was purifed and designated UB2773.
| Generation of S. gordonii complemented mutant strains
To complement the S. gordonii UB2723 ΔpadA mutant, the entire padA coding sequence was cloned into pMSP, a derivative of pMSP7517 (Hirt et al., 2000) in which the prgB gene had been replaced by DNA encoding three alanine residues, together with the transcriptional terminator of the padA operon. In brief, a 227-bp region downstream of SGO_RS09805 incorporating the padA operon transcriptional terminator was amplified from S. gordonii DL1 chromosomal DNA using PrimeSTAR® GXL polymerase (Takara Biotechnology, Shiga, Japan) with primers Terminator.XhoF/Terminator.XhoR. The amplimer was cloned using In-Fusion HD Cloning Kit (Clontech, Oxford, UK) into vector pMSP, which had been linearized by digestion with XhoI. The primers were designed such that only the XhoI site at the 5′ end of the transcriptional terminator would be retained upon cloning. This construct (pMSP-term) was transformed into E. coli K12 and confirmed by sequencing. The padA gene (10,967 BP) was then amplified using primers padA.pMSPF/padA.pMSPR and cloned via XhoI sites at its termini into pMSP-term that had been similarly digested. The resulting construct (pMSP-padA) was transformed into E. coli K12 and confirmed by sequencing. The construct was then transformed into S. gordonii To purify PadA from S. gordonii, plasmid pMSP-padA was used as template in inverse PCR with 5′ phosphorylated primers His.padAR 5′ATGATGATGTGCTCCGTCTTTAATAGATG and His.
padAF CACCACCACTAACTCGAGGAATTAGGTTG to substitute the sequence encoding the PadA wall anchorage motif (LPKTG) with a sequence encoding ×6 His (underlined in primers), followed by a stop codon. Amplicons were ligated following removal of original template by DpnI digestion, and resulting plasmids were transformed into E. coli JM109. Several plasmids were confirmed by sequencing, and then transformed into S. gordonii UB2723 ΔpadA. A representative strain was selected in which padA gene expression was induced with nisin (50 ng ml −1 ), and PadA protein, in the absence of cell wall anchorage motif, was secreted into the growth medium ( Figure S1 ).
Generation of plasmid pMSP-hsa carrying the complete coding sequence of hsa and S. gordonii strain Δhsa/pMSP-hsa (UB1746) have been described previously (Jakubovics et al., 2009 ). To make a complement in S. gordonii UB2773 Δhsa ΔpadA double mutant, pMSP-hsa was transformed into this strain to generate S. gordonii UB2777 Δhsa ΔpadA/pMSP-hsa. The S. gordonii pMSP-hsa complemented strains were induced with nisin (10-50 ng ml −1 ) and subjected to lectin immunoblotting with sWGA to confirm Hsa expression (Jakubovics et al., 2009 ; Figure 2 ).
| Site-directed mutagenesis and protein expression
Site-directed mutagenesis of two potential integrin-recognition sites in the F2 N-terminal region of PadA have been previously described (Keane et al., 2013) . Briefly, alanine-substitution mutagenesis was performed by the use of mutagenic primers containing base mismatches in inverse PCR amplification of pET46-F2, containing the PadA-F2 domain coding sequence to generate pET46-F2 NGR AAA , pET46-F2 RGT AAA or pET46-F2 AGD AAA . In addition to the base mismatches corresponding to the alanine substitutions, a new engineered restriction site was introduced into each plasmid, enabling restriction digest to generate compatible ends for self-ligation to reform a circular plasmid.
A modified alanine substitution method was employed to generate double and triple motif substitutions. In summary, this technique avoided the need for restriction digests to prepare complementary ends and instead made use of 5′ phosphate groups on the primers to enable plasmid self-ligation. pET46-F2 AGD AAA was extracted and purified from E. coli JM109 and used as template DNA for inverse PCR amplification using primers JH5F/JH6R. These primers incorporated 5′phosphate groups and base mismatches to generate both the alanine substitutions and an engineered AgeI site to facilitate screening by restriction digest analysis. Phusion DNA Polymerase (Life Technologies, Paisley, UK) was used in a two-step protocol to generate the desired amplimer of 7200 BP. This was treated with DpnI for 1 hr at 37°C to remove template DNA and subsequently purified. The purified DNA was self-ligated using T4 DNA ligase for 16 hr at 16°C and subsequently transformed into competent E. coli JM109 cells.
Transformants were selected for Ap R , and colonies were screened for plasmids that were cut with AgeI, indicating the formation of pET46-F2 RGT AAA AGD AAA , and this was confirmed by sequencing. Purified plasmid was then transformed into competent E. coli BL21 cells for recombinant protein production (see below).
Generation of a pET46-F2 NGR AAA RGT AAA AGD AAA plasmid construct was achieved using a similar alanine substitution technique to that used to generate the pET46-F2 RGT AAA AGD AAA construct.
Briefly, the template plasmid pET46-F2 RGT AAA AGD AAA was extracted and purified from E. coli JM109. 5′-phosphate-modified JH19F and JH20R primers, which incorporated an engineered NotI restriction site, were used in Phusion PCR to generate the desired amplimer (7200 BP ), which was subsequently treated with DpnI, self-ligated and 
| Mass spectrometry sample preparation
To prepare the eluted samples from the pull-down assays for MS, the samples were subjected to SDS-PAGE until the dye-front had moved 1.5 cm into the gel. The gel was stained with Coomassie blue, destained, and a single gel slice encompassing proteins below 350 kDa was excised. The slice was subjected to in-gel tryptic digestion with a ProGest automated digestion unit (Digilab UK). The resulting peptides were fractionated with a Dionex Ultimate 3000 nanoHPLC system in line with an LTQ-Orbitrap Velos mass spectrometer (Thermo Scientific) controlled by Xcalibur 2.1 software (Thermo Scientific). The Orbitrap was set to analyse the survey scans at 60,000 resolution (at m/z 400) in the mass range m/z 300 to 2,000 and the top twenty multiply-charged ions in each duty cycle were selected for MS/MS in the LTQ linear ion trap.
| Liquid chromatography-mass spectrometry data analysis
The raw data files were processed and quantified using Proteome Dis- full tryptic digestion, and a maximum of one missed cleavage was allowed. The reverse database search option was enabled, and all peptide data were filtered to satisfy false discovery rate (FDR) of 5%.
The Proteome Discoverer software generates a reverse "decoy" database from the same protein database, and any peptides passing the initial filtering parameters that were derived from this decoy database are defined as false positive identifications. The minimum crosscorrelation factor (Xcorr) filter was readjusted for each individual charge state separately to optimally meet the predetermined target FDR of 5% based on the number of random false positive matches from the reverse decoy database. Thus, each data set has its own passing parameters.
| Platelet adherence assay
Whole blood was collected from six donors and added to 1.5 ml acid citrate dextrose per 10 ml blood collected. The donors were healthy subjects who had abstained from taking any non-steroidal antiinflammatory drugs (NSAIDs) in the previous 10 days. Informed consent was obtained from all subjects, and the study was approved by the Royal College of Surgeons in Ireland Ethics Committee (REC679b).
Blood was centrifuged (150 × g, 10 min), and the upper plateletcontaining fraction was carefully removed to a fresh tube. The platelet-rich plasma (PRP; collected in acid-citrate dextrose, ACD) was adjusted to pH 6.5 with ACD. Apyrase (1 U ml −1 ), and prostaglandin-E1 (Sigma Aldrich; 2 μM) were added to the PRP, and the sample was centrifuged (650 × g, 10 min, 20°C). The upper layer containing platelet-poor plasma was removed, and the platelet pellet was suspended in 2 ml modified HEPES-Tyrode buffer (JNL; 6 mM dextrose, 130 mM NaCl, 9 mM NaHCO 3 , 10 mM Na citrate, 10 mM Tris base, 3 mM KCl, 0.8 mM KH 2 PO 4 , 0.9 mM MgCl 2 , pH 7.4). The platelet suspension was then applied to a chromatography column containing 5 ml packed Sepharose 2B-300, previously equilibrated with JNL buffer. The platelet concentration was determined using a Sysmex-100 particle counter (Sysmex, Kobe, Japan).
Static platelet adhesion assay was performed as described previously (Kerrigan et al., 2002 
| Platelet spreading assay
Poly-L-lysine-coated glass slides were coated with PadA protein fragment (100 μg ml −1 ) for 16 hr at 4°C. Slides were then blocked with 1% BSA; washed and gel-filtered platelets (5 × 10 6 platelets ml ) were allowed to spread on the PadA fragments for 45 min at 37°C. The slides were washed, the platelets were fixed and permeabilized, and then the samples were stained with Alexa 546 phalloidin and examined by confocal microscopy as described in detail elsewhere (Keane et al., 2013) . The percentage of platelets spread was calculated from five areas, selected randomly, containing 200 or more total cells.
| Bacterial cell adhesion assays
Extracellular matrix proteins in coating buffer (20 mM Na 2 CO 3 , 2 mM NaHCO 3 , pH 9.3) were added to the wells of a high-binding 96-well plate (Immulon 2HB) and incubated for 16 hr at 4°C. In some experiments, immobilized substrata were then desialylated with 0.001 U neuraminidase from Clostridium perfringens (Sigma) in 0.1 M sodium acetate buffer (pH 5.0) containing 2 mM CaCl 2 , for 2 hr at 37°C. Wells were washed once in TBSC (10 mM Tris-HCl pH 7.6, 0.15 M NaCl, 5 mM CaCl 2 ), and non-specific binding sites blocked with 3% BSA in TBSC containing 0.05% Tween-20 (TBST) for 1 hr at 37°C. Bacterial cultures were grown for 16 hr at 37°C, and cells were harvested by centrifugation (5000 × g, 7 min). Cells were washed once in TBSC, adjusted to OD 600 0.5, and portions (0.1 ml) incubated with the immobilized proteins at 37°C for 2 hr. The suspensions were then removed, and the wells were washed twice in TBS. Adherent cells were fixed with 25% formaldehyde for 30 min at room temperature.
Wells were washed twice in TBS, 0.5% crystal violet was added, and the plates were incubated for 2 min at room temperature. Wells were washed three times in TBS, 10% acetic acid (0.1 ml) was added and after 5 min, levels of adhesion were quantified by measuring absorbance at 595 nm (A 595 ). Previous work has shown that bacterial cell numbers are proportional to A 595 over the range employed in the assays (Jakubovics et al., 2005) .
| Salivary pellicle adhesion assay
Saliva was collected from at least six healthy adult human subjects, who provided written informed consent (approved by the National
Research Ethics Committee South Central Oxford C. 165 # 08/ H0606/87 + 5). Exclusion criteria were: antimicrobial medication within 7 days previously, continuous medication, gross dental caries, or unstable periodontal disease. Samples were pooled, mixed with 0.25 M dithiothreitol on ice for 10 min and clarified by centrifugation (8000 × g, 10 min). The supernatant was diluted to 10% with sterile water, filter sterilized (0.22 μm pore membrane) and aliquots were stored at −20°C.
Saliva-coated cover slips were prepared by placing sterile 19-mm-diameter cover slips (Menzel-Glaser, Braunschweig, Germany)
into 12-well plates (Greiner) and adding 10% saliva (1 ml) to each well. The cover slips were incubated at 4°C for 16 hr, washed with PBS, and transferred to a fresh 12-well plate. Bacterial cell suspension (OD 600 0.5) was added to each well as described above, incubated at 37°C for 2 hr, and aspirated from the wells, and the cover slips were washed twice in TBSC. Adherent cells were fixed and stained with crystal violet, and levels of adhesion were quantified by A 595 measurement.
| Biofilm formation
Bacterial cultures grown for 16 hr (10 ml) were harvested by centrifugation (5000 × g, 7 min), washed in modified C (mC) medium (0.25% Difco Proteose Peptone #2, 0.75% yeast extract, 10 mM K 2 HPO 4 , 0.4 mM MgSO 4 .7H 2 O, 17 mM NaCl, pH 7.5, containing 0.2% glucose) and adjusted to OD 600 1.0 in mC medium. Saliva-coated cover slips were prepared as above in 12-well plates (Greiner) before bacterial cell suspension (OD 600 0.5) was added to each well. The plates were incubated at 37°C for 1 hr with shaking at 50 r.p.m. The cell suspensions were removed and the cover slips washed twice in mC medium. Fresh mC medium was then added to each well and the plates were incubated at 37°C for a further 15 hr. Cover slips were then removed, washed twice in PBS, and stained with crystal violet as described above.
| Recombinant protein binding assays
ECM proteins in coating buffer (50 μl) were added to wells of a highbinding 96-well plate (Immulon 2HB) and incubated for 16 hr at 4°C.
Wells were washed once in TBSC and non-specific binding sites were blocked with 3% BSA in TBSC for 1 hr at 37°C. Wells were washed once in TBSC and recombinant protein (0-5 μg) diluted in TBSC was applied to the wells and incubated for 1 hr at 37°C. Unbound protein was removed and wells washed once in TBS. Primary antibody diluted in TBST was added to the wells and incubated for 1 hr at 37°C. Wells were washed twice in TBST before adding HRP-linked secondary antibody diluted in TBST containing 3% BSA and incubating for 1 hr at 37°C.
Wells were washed once in TBST, twice in TBS, and detection reagent (0.102 M Na 2 HPO 4 , 0.049 M citric acid, 0.012% H 2 O 2 , 3.7 mM o-phenylenediamine) was added to wells. Plates were incubated in the dark for 10 min at room temperature, 0.56 M H 2 SO 4 was added to stop the reactions and A 490 measured. x6His-tagged proteins were detected using anti-tetraHis antibody (Qiagen) at 1:1000 dilution and HRP-conjugated anti-mouse antibody (Dako) at 1:2000 dilution. Fibrinogen was detected using rabbit anti-human fibrinogen antibody (Dako) at 1:1000 dilution and HRP-conjugated swine anti-rabbit antibody (Dako) at 1:2000 dilution.
